Source: DGNews | Posted 8 years ago
FDA Approves New Indication for Arixtra (Fondaparinux Sodium), Extended Prophylaxis of Deep Venous Thrombosis in Patients Undergoing Hip Fracture Surgery
Tags:
PARIS, FRANCE -- June 18, 2003 -- Sanofi-Synthelabo and Organon announced today that Arixtra



Comments